156 related articles for article (PubMed ID: 24746199)
1. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
[TBL] [Abstract][Full Text] [Related]
2. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
4. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Chung TK; Cheung TH; Huen NY; Wong KW; Lo KW; Yim SF; Siu NS; Wong YM; Tsang PT; Pang MW; Yu MY; To KF; Mok SC; Wang VW; Li C; Cheung AY; Doran G; Birrer MJ; Smith DI; Wong YF
Int J Cancer; 2009 Mar; 124(6):1358-65. PubMed ID: 19065659
[TBL] [Abstract][Full Text] [Related]
7. Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers.
Kalinkova L; Kajo K; Karhanek M; Wachsmannova L; Suran P; Zmetakova I; Fridrichova I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842533
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
[TBL] [Abstract][Full Text] [Related]
11. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma.
Planagumà J; Díaz-Fuertes M; Gil-Moreno A; Abal M; Monge M; García A; Baró T; Thomson TM; Xercavins J; Alameda F; Reventós J
Cancer Res; 2004 Dec; 64(24):8846-53. PubMed ID: 15604243
[TBL] [Abstract][Full Text] [Related]
12. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
13. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
[TBL] [Abstract][Full Text] [Related]
15. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
[TBL] [Abstract][Full Text] [Related]
16. Stromal signatures in endometrioid endometrial carcinomas.
Espinosa I; Catasus L; D' Angelo E; Mozos A; Pedrola N; Bértolo C; Ferrer I; Zannoni GF; West RB; van de Rijn M; Matias-Guiu X; Prat J
Mod Pathol; 2014 Apr; 27(4):631-9. PubMed ID: 24263966
[TBL] [Abstract][Full Text] [Related]
17. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Gonzalez M; Doll A; Monge M; Gil-Moreno A; Baró T; García A; Xercavins J; Alameda F; Abal M; Reventós J
Hum Pathol; 2006 Aug; 37(8):1050-7. PubMed ID: 16867868
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
[TBL] [Abstract][Full Text] [Related]
19. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.
Yang Y; Zhou L; Lu L; Wang L; Li X; Jiang P; Chan LK; Zhang T; Yu J; Kwong J; Cheung TH; Chung T; Mak K; Sun H; Wang H
Oncogene; 2013 Jul; 32(29):3432-42. PubMed ID: 22907428
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
